Cullinan Therapeutics Announces Positive Initial Data from P

CAMBRIDGE, Mass., June 01, 2024 -- Cullinan Therapeutics, Inc. , a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced positive initial data in...

Related Keywords

Virginia , United States , Cambridge , Cambridgeshire , United Kingdom , Chad , American , Rose Weldon , Jeffrey Jones , Jeff Jones , Alexander Spira , Globenewswire Inc , Linkedin , Nasdaq , American Society Of Clinical Oncology Annual Meeting , Virginia Cancer Specialists Research Institute , Taiho Pharmaceutical Co Ltd , Taiho Oncology Inc , Cullinan Pearl Corp , Exchange Commission , Cullinan Therapeutics Inc , Greater China To Zai Lab , Chief Medical Officer , Olive Investor , Investor Event , Cullinan Therapeutics , Clinical Oncology Annual , Cancer Specialists Research Institute , Breakthrough Therapy Designation , Pearl Corp , Zai Lab Limited , Private Securities Litigation Reform Act , Annual Report ,